Selective PPAR-Delta/PPAR-Gamma Activation Improves Cognition in a Model of Alzheimer’s Disease is a research paper published in Cells (2023). On theSindex it has a DataRank of 0. It has been cited 23 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: NIH1R15AG048643
NIH
Grant: NIH-1R43AG065069-01
NIH HHS
Grant: NIH R42AG065069-03A1
NIA NIH HHS
Grant: R43 AG065069
NIA NIH HHS
Grant: R15 AG048643
NIA NIH HHS
Grant: 1R43AG065069-01
Evaluation of a selective PPAR-gamma agonist for treatment of Alzheimer’s Disease
NIA NIH HHS
Grant: R42 AG065069
National Institutes of Health
Grant: 1R15AG048643-01A1
Novel PPAR-gamma agonist selectively activate the ligand binding domain of PPAR-gamma and improve pathology and memory deficits in a 3xTg-Ad mouse model.
Fields of Study
MeSH Terms
Keywords